EXTH-29. INHIBITION OF LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A (KDM1A/LSD1) SENSITIZES GLIOBLASTOMA CELLS TO CHEMO AND RADIATION THERAPY

BACKGROUND: Despite treatment advances, glioblastoma (GBM) is the deadliest tumor of the central nervous system. Patients face a dismal 15-month median survival and average 5-year survival rate of 13%. Current standard of care includes surgical resection, external beam radiation therapy, and adjuvan...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Neuro Oncol
Hoofdauteurs: Alejo, Salvador, Palacios, Bridgitte, Venkata, Prabhakar Pitta, Chen, Yihong, He, Yi, Viswanadhapalli, Suryavathi, Pratap, Uday, Zheng, Siyuan, Brenner, Andrew, Vadlamudi, Ratna, Sareddy, Gangadhara
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2020
Onderwerpen:
Preclinical Experimental Therapeutics
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651145/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.383
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items